{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:37:35Z","timestamp":1793407055683,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.humpath.2017.02.001","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T19:32:50Z","timestamp":1487705570000},"page":"232-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as \"cholangioblastic variant of intrahepatic cholangiocarcinoma\u201d"],"prefix":"10.1016","volume":"62","author":[{"given":"David R.","family":"Braxton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Saxe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevena","family":"Damjanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Stashek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuti","family":"Shroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer D.","family":"Morrissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Tondon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma E.","family":"Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2017.02.001_bb0005","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-2004-828889","article-title":"The epidemiology of cholangiocarcinoma","volume":"24","author":"Shaib","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.humpath.2017.02.001_bb0010","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.gcb.2010.01.008","article-title":"Cholangiocarcinoma: descriptive epidemiology and risk factors","volume":"34","author":"de Martel","year":"2010","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.humpath.2017.02.001_bb0015","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12029-008-9040-0","article-title":"Cholangiocarcinoma: expanding the spectrum of risk factors","volume":"39","author":"Elfaki","year":"2008","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.humpath.2017.02.001_bb0020","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/13651820801992641","article-title":"Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma","volume":"10","author":"Khan","year":"2008","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.humpath.2017.02.001_bb0025","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study","volume":"5","author":"Welzel","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2017.02.001_bb0030","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1007\/s10620-014-3276-2","article-title":"Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification","volume":"59","author":"Tyson","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.humpath.2017.02.001_bb0035","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s00428-005-1241-3","article-title":"Hepatic adenocarcinoma expressing inhibin in a young patient on oral contraceptives","volume":"446","author":"Vrettou","year":"2005","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2017.02.001_bb0040","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2017.02.001_bb0045","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cancergen.2013.11.005","article-title":"Understanding the limitations of next-generation sequencing informatics, an approach to clinical pipeline validation using artificial data sets","volume":"206","author":"Daber","year":"2013","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.humpath.2017.02.001_bb0050","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/ijc.30196","article-title":"Clinicopathogenomic analysis of mismatch repair proficient colorectal adenocarcinoma uncovers novel prognostic subgroups with differing patterns of genetic evolution","volume":"139","author":"Braxton","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2017.02.001_bb0055","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/gcc.20510","article-title":"Allelic alterations in well-differentiated neuroendocrine tumors (carcinoid tumors) identified by genome-wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors","volume":"47","author":"Kim do","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2017.02.001_bb0060","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1677\/ERC-09-0052","article-title":"High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids","volume":"16","author":"Andersson","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2017.02.001_bb0065","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","article-title":"Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes","volume":"144","author":"Sia","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2017.02.001_bb0070","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.1038\/sj.onc.1209537","article-title":"Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays","volume":"25","author":"Midorikawa","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2017.02.001_bb0075","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.humpath.2008.11.005","article-title":"Pattern of chromosomal aberrations in primary liver cancers identified by comparative genomic hybridization","volume":"40","author":"Homayounfar","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2017.02.001_bb0080","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/jemt.22404","article-title":"Human fetal ductal plate revisited. I. Ductal plate expresses NCAM, KIT, MET, PDGFRA, and neuroendocrine antigens (NSE, chromogranin, synaptophysin, and CD56)","volume":"77","author":"Terada","year":"2014","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.humpath.2017.02.001_bb0085","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/00000478-199009000-00006","article-title":"Neuroendocrine differentiation in hepatoblastoma. An immunohistochemical investigation","volume":"14","author":"Ruck","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2017.02.001_bb0090","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/PAI.0b013e3181d2ed4c","article-title":"Detection of bone marrow metastases of neuroblastoma with immunohistochemical staining of CD56, chromogranin a, and synaptophysin","volume":"18","author":"Park","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2017.02.001_bb0095","first-page":"884","article-title":"Pulmonary blastoma. Comparison between its epithelial components and fetal bronchial epithelium","volume":"42","author":"Inoue","year":"1992","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.humpath.2017.02.001_bb0100","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/mpo.10173","article-title":"Hepatoblastoma with cholangioblastic features (\u2018cholangioblastic hepatoblastoma') and other liver tumors with bimodal differentiation in young patients","volume":"39","author":"Zimmermann","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.humpath.2017.02.001_bb0105","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/1097-0142(19910501)67:9<2368::AID-CNCR2820670926>3.0.CO;2-G","article-title":"Pulmonary blastomas","volume":"67","author":"Koss","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2017.02.001_bb0110","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11748-006-0048-8","article-title":"Resected well-differentiated fetal pulmonary adenocarcinoma and summary of 25 cases reported in Japan","volume":"54","author":"Sato","year":"2006","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.humpath.2017.02.001_bb0115","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4161\/cc.5.2.2341","article-title":"Control of hepatic differentiation by activin\/TGFbeta signaling","volume":"5","author":"Clotman","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.humpath.2017.02.001_bb0120","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1101\/gad.340305","article-title":"Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors","volume":"19","author":"Clotman","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.humpath.2017.02.001_bb0125","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/hep.21952","article-title":"Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate","volume":"47","author":"Decaens","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2017.02.001_bb0130","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/jhep.2000.8535","article-title":"Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells","volume":"32","author":"Yokomuro","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2017.02.001_bb0135","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.mrrev.2006.07.002","article-title":"The activin axis in liver biology and disease","volume":"613","author":"Rodgarkia-Dara","year":"2006","journal-title":"Mutat Res"},{"key":"10.1016\/j.humpath.2017.02.001_bb0140","first-page":"3415","article-title":"The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours","volume":"19","author":"Ferrari","year":"1999","journal-title":"Anticancer Res"},{"key":"10.1016\/j.humpath.2017.02.001_bb0145","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1677\/joe.0.1510225","article-title":"Plasma levels of chromogranin a are directly proportional to tumour burden in neuroblastoma","volume":"151","author":"Wassberg","year":"1996","journal-title":"J Endocrinol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717300461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817717300461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:53:54Z","timestamp":1536022434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817717300461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":29,"alternative-id":["S0046817717300461"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2017.02.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as \"cholangioblastic variant of intrahepatic cholangiocarcinoma\u201d","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2017.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}